Skip to main content

Year: 2020

Mount Logan Capital Inc. Announces Acquisition of $662 million CLO Platform and U.S. Investment Advisor Registration of Subsidiary

THIS NEWS RELEASE IS NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES FOR DISSEMINATION IN THE UNITED STATESAll figures in United States dollars unless otherwise noted.TORONTO, Nov. 12, 2020 (GLOBE NEWSWIRE) — Mount Logan Capital Inc. (NEO: MLC) (“Mount Logan” or the “Company”) is pleased to announce that Mount Logan Management, LLC (“ML Management”), a wholly-owned subsidiary of the Company, pursuant to an asset purchase agreement entered into on August 21, 2020 (the “CLO Agreement”), has completed its acquisition from Garrison Investment Management LLC (“GIM”) and other sellers (collectively with GIM, “Sellers”) of the rights of GIM under certain investment management agreements, the general partnership interests of an affiliate of GIM under certain partnership agreements, the rights of certain Sellers under certain collateral management...

Continue reading

MediciNova Announces Presentation of Positive Findings on MN-001 (tipelukast) in Acute Liver Injury Model at The Liver Meeting Digital Experience™ 2020

LA JOLLA, Calif., Nov. 12, 2020 (GLOBE NEWSWIRE) — MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market (NASDAQ:MNOV) and the JASDAQ Market of the Tokyo Stock Exchange (Code Number: 4875), today announced that Principal Investigators Leila Gobejishvili, PhD and Craig McClain, MD at the University of Louisville School of Medicine presented positive results of the in-vitro and in-vivo studies that evaluated MN-001 (tipelukast, referred to as D46 in the presentation) for its anti-liver fibrotic effect in human hepatic stellate cells (HSCs) and in an acute liver injury model at the Liver Meeting Digital Experience™ 2020 (TLMdX™), the annual meeting of the American Association for the Study of Liver Diseases (AASLD).The study was a collaborative effort between MediciNova, Inc., and Drs. Craig McClain and Leila...

Continue reading

Keros Therapeutics Announces Pricing of Public Offering of Common Stock

LEXINGTON, Mass., Nov. 12, 2020 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros”) (Nasdaq: KROS), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of novel treatments for patients suffering from hematological and musculoskeletal disorders with high unmet medical need, today announced the pricing of its public offering of 2,600,000 shares of common stock at a price to the public of $50.00 per share. The gross proceeds to Keros from the offering, before deducting underwriting discounts and commissions and offering expenses, are expected to be $130.0 million. All securities in the offering are being offered by Keros. In addition, Keros has granted the underwriters a 30-day option to purchase up to an additional 390,000 shares of common stock at the public offering price, less...

Continue reading

Retirement of Director from Orocobre Board

BRISBANE, Australia, Nov. 13, 2020 (GLOBE NEWSWIRE) — Orocobre Limited (ASX: ORE, TSX: ORL) (“Orocobre” or “the Company”) wishes to advise that Mr. Federico (Freddy) Nicholson will retire from the Board effective 30 November 2020.Orocobre Chairman Robert Hubbard stated that his board colleagues and the management of Orocobre are immensely appreciative of everything Freddy has brought to the Company, “Freddy has been a wise counsel for the Orocobre Board and management team since joining us back in September 2010. Freddy has brought great insight into how to build a successful business in Argentina and Jujuy in particular.“In the ten years Freddy has served on the Orocobre Board he has been a member of the People and Governance Committee, Sustainability Committee and the Related Party Committee. Freddy is a highly respected business...

Continue reading

Orocobre 2020 Annual General Meeting Transcripts

BRISBANE, Australia, Nov. 13, 2020 (GLOBE NEWSWIRE) — Orocobre Limited (ASX: ORE, TSX: ORL) (“Orocobre” or “the Company”) wishes to provide the Chairman and MD/CEO presentation transcripts for the FY20 Annual General Meeting.Chairman ScriptBefore commencing our meeting today, I would like to take this opportunity to acknowledge the Traditional Owners of the many lands on which are all meeting. In Brisbane we are meeting on the lands of the Turrbal and Yugara people. I recognise their continuing connection to land, water and community, and I pay my respects to their elders, past, present and emerging.I will now make a short address to the meeting which will be followed by a presentation by our CEO and Managing Director, Martín Pérez de Solay. There will then be an opportunity for shareholders to ask questions on any aspect of the...

Continue reading

Vislink Technologies Reports Q3 2020 Financial Results

HACKETTSTOWN, NJ , Nov. 12, 2020 (GLOBE NEWSWIRE) — Vislink Technologies, Inc. (“Vislink” or the “Company”) (Nasdaq: VISL) announced its results for the third quarter ended September 30, 2020. Company management will host a live webcast on Friday, November 13, 2020 at approximately 10:00 a.m. ET to review the Company’s financial and operating results and provide a general business update (see webcast details below).Financial HighlightsRevenues for the three months ended September 30, 2020 were $4.8 million, compared to $5 million for the three months ended September 30, 2019.EBITDA (earnings before interest, taxes depreciation and amortization) was a negative $2.4 million for the three months ended September 30, 2020, compared to a negative $4.7 million for the three months ended September 30, 2019.Ended the third quarter 2020 with...

Continue reading

High Arctic Announces 2020 Third Quarter Financial and Operating Results

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES. ANY FAILURE TO COMPLY WITH THIS RESTRICTION MAY CONSTITUTE A VIOLATION OF U.S. SECURITIES LAWCALGARY, Alberta, Nov. 12, 2020 (GLOBE NEWSWIRE) — High Arctic Energy Services Inc. (TSX: HWO) (the “Corporation” or “High Arctic”) released its third quarter results today.Mike Maguire, Chief Executive Officer commented:“The health and economic environments have remained challenging through this quarter. The action we took in April to restructure and flatten our management reporting lines, remove costs, suspend our dividend and reduce our capex have ensured that we can navigate this period focused on high quality safe and effective operations, maintaining the health of our employees and our stellar QHSE reputation.We recognize the importance of communication,...

Continue reading

Aequus Announces Anne Stevens’ Leadership Change

VANCOUVER, British Columbia, Nov. 12, 2020 (GLOBE NEWSWIRE) — Aequus Pharmaceuticals Inc. (TSX-V: AQS, OTCQB: AQSZF), a specialty pharmaceutical company with a focus on developing, advancing and promoting differentiated products announces Ms Anne Stevens is stepping down from her role as Chief Operating Officer. Ms Stevens will remain a Director and will continue to serve on the Aequus Board of Directors.“Anne and I co-founded Aequus together and I want to thank her for her many contributions over the years,” said Doug Janzen, Chairman and CEO of Aequus. “Anne is an incredibly talented and effective executive who is leaving the company in excellent shape and well positioned for success in the years to come. We are excited about her future plans and look forward to her continued work with the Aequus Board.”“I want to thank my fellow...

Continue reading

Aura Declares Commercial Production at Ernesto Project in EPP

ROAD TOWN, British Virgin Islands, Nov. 12, 2020 (GLOBE NEWSWIRE) — Aura Minerals Inc. (TSX: ORA) (B3: AURA33) (the “Company” or “Aura”) is pleased to announce that the Ernesto open pit mine (“Ernesto mine”), part of the Ernesto/Pau-a-Pique mine complex (“EPP”), located in the southwest of Mato Grosso state, near Pontes e Lacerda in Brazil, has declared commercial production effective October 1, 2020. In October 2020 production achieved 2,507 ounces of gold in the Ernesto mine alone.Thanks to the contribution from the Ernesto mine, in October 2020 EPP achieved its highest production since the 2016 start-up, with 8,233 of ounces of gold produced.At Ernesto, the Company expects an increase in production in the fourth quarter of 2020. Following this, the Company plans a push back in the mine in order to access high grade ore by Q4...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.